SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001385508-18-000074
Filing Date
2018-09-10
Accepted
2018-09-10 16:36:41
Documents
4
Period of Report
2018-09-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K opiant_8-kseptember102018.htm 8-K 34374
2 EXHIBIT 10.84 opiant_consortxfinaldevagmt.htm EX-10.84 306614
3 EXHIBIT 10.85 opiant_consortxfinalreimba.htm EX-10.85 87959
4 EXHIBIT 99.1 pr_consortmedicalforopnt00.htm EX-99.1 12381
  Complete submission text file 0001385508-18-000074.txt   442709
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38193 | Film No.: 181063166
SIC: 1000 Metal Mining